Valor202020212022202320242025TTMDespesas comerciais, gerais e administrativas14.2 B14.89 B14.25 B12.52 B12.57 B13.25 B—Pesquisa e desenvolvimento8.98 B9.54 B10 B11.37 B10.02 B11.2 B—Lucro operacional10.15 B11.69 B9.2 B9.77 B14.54 B17.64 B—Lucro não operacional, total———————Despesa com juros, líquida de juros capitalizados———————Receitas não operacionais, líquidas das despesas com juros———————Receitas/despesas incomuns———————Lucro antes dos impostos9.88 B26.14 B2.38 B596 M3.54 B329 M—Participação no lucro———————Impostos1.81 B2.12 B1.42 B551 M1.7 B2.38 B—Participação de minoritários1 M3 M04 M2 M17 M—Outras receitas/despesas após impostos———————Lucro líquido antes das operações descontinuadas3.48 B19.43 B6.96 B8.57 B5.66 B7.68 B—Operações descontinuadas4.59 B4.59 B—6.28 B6.28 B6.28 B—Lucro líquido8.07 B24.02 B6.96 B14.85 B11.94 B13.97 B—Ajuste de diluição———————Dividendos de ações preferenciais———————Lucro líquido diluído disponível aos acionistas———————Lucro básico por ação———————Lucro diluído por ação———————Número médio de ações básicas———————Ações diluídas———————EBITDA———————EBIT———————Custo da receita15.12 B15.87 B15.49 B12.47 B12.83 B13.7 B—Outros componentes do custo———————Amortização e depreciação (fluxo de caixa)———————
Novartis AG
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz.